0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Hamster Ovary Cell CHO Hepatitis B Vaccine Market Insights Forecast to 2025
Published Date: March 2019
|
Report Code: QYRE-Othe-291
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Recombinant Hamster Ovary Cell CHO Hepatitis B Vaccine Market Insights Forecast to 2025

Global Recombinant Hamster Ovary Cell CHO Hepatitis B Vaccine Market Insights Forecast to 2025

Code: QYRE-Othe-291
Report
March 2019
117 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures


"Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chinese hamster ovary cell (CHO) hepatitis B vaccine is considered to be the safe and effective method to prevent the hepatitis B infection. The major factor that fuels the growth of the market are increase in prevalence of hepatitis B infection worldwide. For example, approximately 887,000 deaths due to hepatitis B infection were recorded in 2015 across the globe. However, inherent disadvantages of using recombinant Chinese hamster ovary cell (CHO) to design hepatitis B vaccines restrains the growth of the market. Conversely, increase in government focus to promote (CHO) hepatitis B vaccination for adults and extensive research carried out for the same are expected to offer lucrative opportunities for the market.
The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in these regions.
This research report categorizes the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market by top players/brands, region, type and end user. This report also studies the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck & Co., Inc.
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson

Market size by Product
Pediatric Hepatitis B (CHO) Vaccine
Adult Hepatitis B (CHO) Vaccine
Market size by End User
Hospitals
Clinics

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
"

 

 

 

 

"Table of Contents

1 Study Coverage
1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate by Product
1.4.2 Pediatric Hepatitis B (CHO) Vaccine
1.4.3 Adult Hepatitis B (CHO) Vaccine
1.5 Market by End User
1.5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size
2.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue 2014-2025
2.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 2014-2025
2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Growth Rate by Regions
2.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Regions
2.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers
3.1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers
3.1.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Manufacturers
3.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers
3.2.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Manufacturers
3.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Product
4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Product
4.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by End User

6 North America
6.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Countries
6.1.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries
6.1.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Product
6.3 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by End User

7 Europe
7.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Countries
7.1.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries
7.1.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Product
7.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by End User

8 Asia Pacific
8.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Countries
8.1.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries
8.1.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Product
8.3 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by End User

9 Central & South America
9.1 Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Countries
9.1.1 Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries
9.1.2 Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Product
9.3 Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by End User

10 Middle East and Africa
10.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Countries
10.1.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries
10.1.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Product
10.3 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by End User

11 Company Profiles
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Company Details
11.1.2 Company Business Overview
11.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
11.1.5 Merck & Co., Inc. Recent Development
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
11.2.5 GlaxoSmithKline Plc Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
11.3.5 Pfizer Inc. Recent Development
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
11.4.5 Sanofi Pasteur Recent Development
11.5 CSL Limited
11.5.1 CSL Limited Company Details
11.5.2 Company Business Overview
11.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
11.5.5 CSL Limited Recent Development
11.6 Emergent Biosolutions
11.6.1 Emergent Biosolutions Company Details
11.6.2 Company Business Overview
11.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
11.6.5 Emergent Biosolutions Recent Development
11.7 Serum Institute of India
11.7.1 Serum Institute of India Company Details
11.7.2 Company Business Overview
11.7.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
11.7.5 Serum Institute of India Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Company Business Overview
11.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
11.8.5 Johnson & Johnson Recent Development

12 Future Forecast
12.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast by Regions
12.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Forecast by Regions 2019-2025
12.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast by Product
12.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Forecast by Product 2019-2025
12.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast by End User
12.4 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecast
12.5 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecast
12.6 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecast
12.7 Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecast
12.8 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
"

"List of Tables and Figures

Figure Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Picture
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segments
Table Key Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Covered
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Product 2014-2025
Figure Pediatric Hepatitis B (CHO) Vaccine Product Picture
Table Major Manufacturers of Pediatric Hepatitis B (CHO) Vaccine
Figure Adult Hepatitis B (CHO) Vaccine Product Picture
Table Major Manufacturers of Adult Hepatitis B (CHO) Vaccine
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Hospitals
Figure Clinics
Figure Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Report Years Considered
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size 2014-2025 (Million US$)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 2014-2025 (K Doses)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Regions 2014-2019
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Regions
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Regions
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (2014-2019) (USD/Dose)
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Type
Table Date of International Manufacturers Enter into Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Product (2014-2019) (K Doses)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Product (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Product (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Product in 2018
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Product (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Product in 2018
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Product 2014-2019 (USD/Dose)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by End User (2014-2019) (K Doses)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by End User (2014-2019)
Figure Global Sales Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by End User in 2018
Figure North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries (2014-2019) (K Doses)
Table North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Countries
Table North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Countries
Figure United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Product (2014-2019) (K Doses)
Table North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Product
Table North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by End User (2014-2019) (K Doses)
Table North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by End User
Figure Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries (2014-2019) (K Doses)
Table Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Countries
Table Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Countries
Figure Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure UK Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Product (2014-2019) (K Doses)
Table Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Product
Table Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by End User (2014-2019) (K Doses)
Table Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by End User
Figure Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Countries
Table Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Countries
Figure China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Product (2014-2019) (K Doses)
Table Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Product
Table Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by End User (2014-2019) (K Doses)
Table Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by End User
Figure Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries (2014-2019) (K Doses)
Table Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Countries
Table Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Countries
Figure Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Product (2014-2019) (K Doses)
Table Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Product
Table Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by End User (2014-2019) (K Doses)
Table Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by End User
Figure Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Countries
Table Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Countries
Figure GCC Countries Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Product
Table Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by End User
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Merck & Co., Inc. Recent Development

Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Recent Development

Table Pfizer Inc. Company Details
Table Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Pfizer Inc. Recent Development

Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Pasteur Recent Development

Table CSL Limited Company Details
Table CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table CSL Limited Recent Development

Table Emergent Biosolutions Company Details
Table Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Emergent Biosolutions Recent Development

Table Serum Institute of India Company Details
Table Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Serum Institute of India Recent Development

Table Johnson & Johnson Company Details
Table Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development

Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Product 2019-2025 (K Doses)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by End User 2019-2025 (K Doses)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Chain
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers List
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
"

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows multiple user to access the PDF.

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global and China Elspar Market Insights Forecast to 2027
Global and China Elspar Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-9G6884
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and United States Clofarabine Drugs Market Insights Forecast to 2027
Global and United States Clofarabine Drugs Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-0G7032
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and Japan Dasatinib Drugs Market Insights Forecast to 2027
Global and Japan Dasatinib Drugs Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-26C6576
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and China Independent Clinical Laboratories ICL Market Insights Forecast to 2027
Global and China Independent Clinical Laboratories (ICL) Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-30O6445
Sun Sep 05 00:00:00 UTC 2021

Add to Cart